Delving into the Latest Updates on Hebei Jiheng (Group) Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Respiratory Diseases

Otorhinolaryngologic Diseases

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Immune System Diseases	1
Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

COXs x α-adrenergic receptor	1

This article is mainly to investigate the factors on the refining process of folic acid. The appropriate refining process (complex refining combined acid followed by alkali treatment) was proposed. The synthetic crude folic acid was treated firstly with sulfuric acid with the concentration of 30%, then re-purified with sodium hydroxide to give folic acid with the purity of 97% and total yield of 51.3%. Higher temperature (80-100°C) is desired for the crystallization of folic acid. The product treated in this process meets the requirements of CP, USP and BP.

100 Deals associated with Hebei Jiheng (Group) Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Hebei Jiheng (Group) Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 05 Mar 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data